3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
8
Breast Neoplasms
8
Neoplasms
7
Depression
6
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Follicular
5
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Lymphoma, Mantle-Cell
3
Lymphoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Head and Neck Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Anxiety Disorders
3
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Prostatic Hyperplasia
2
Myeloproliferative Disorders
2
Myelodysplastic Syndromes
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell, Marginal Zone
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Kidney Neoplasms
2
Fatigue
2
Interventions
Cisplatin
32
Gemcitabine
21
Radiotherapy, Intensity-Modulated
16
toripalimab
14
Capecitabine
11
Magnetic Resonance Spectroscopy
10
Specimen Handling
9
Radiotherapy
7
Drug Therapy
7
pembrolizumab
6
Platinum
6
Nivolumab
6
Immune Checkpoint Inhibitors
6
1,2-diaminocyclohexaneplatinum II citrate
6
Docetaxel
5
tislelizumab
4
spartalizumab
4
camrelizumab
4
sintilimab
3
anlotinib
3
Immunoglobulin G
3
Disulfides
3
Carboplatin
3
nimotuzumab
2
fludarabine
2
atezolizumab
2
Taxes
2
Radiation
2
Phantoms, Imaging
2
Ipilimumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Nasopharyngeal Carcinoma
×
Therapeutics
×
1 year
×
Clear all
No trials found.